INTERNATIONAL PATENT: ARENA PHARMACEUTICALS, INC. FILES APPLICATION FOR "BEXICASERIN FOR USE IN A METHOD OF TREATMENT OF SEIZURE-INDUCED SUDDEN UNEXPECTED DEATH IN EPILEPSY"

GENEVA, March 3 -- ARENA PHARMACEUTICALS, INC. (66 Hudson Boulevard EastNew York, New York 10007-2192) filed a patent application (PCT/US2025/041546) for "BEXICASERIN FOR USE IN A METHOD OF TREATMENT OF SEIZURE-INDUCED SUDDEN UNEXPECTED DEATH IN EPILEPSY" on Aug 11, 2025. With publication no. WO/2026/043678, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PETERS, Marco (c/o Longboard Pharmaceuticals, Inc.4275 Executive Square, Suite 950La Jolla, California 92037), VERMUDEZ, Sheryl Anne Daguimol (c/o Longboard Pharmaceutic...